News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
376,089 Results
Type
Article (25740)
Company Profile (70)
Press Release (350279)
Section
Business (104280)
Career Advice (450)
Deals (16891)
Drug Delivery (47)
Drug Development (47521)
Employer Resources (49)
FDA (12232)
Job Trends (8443)
News (185879)
Policy (19394)
Tag
Academia (1730)
Alliances (26631)
Alzheimer's disease (736)
Approvals (12234)
Artificial intelligence (100)
Bankruptcy (136)
Best Places to Work (6881)
Breast cancer (132)
Cancer (887)
Cardiovascular disease (78)
Career advice (411)
Cell therapy (143)
Clinical research (39673)
Collaboration (266)
Compensation (63)
COVID-19 (1459)
C-suite (64)
Data (958)
Diabetes (110)
Diagnostics (3388)
Earnings (36078)
Events (50783)
Executive appointments (249)
FDA (12777)
Funding (231)
Gene therapy (78)
GLP-1 (331)
Government (2997)
Healthcare (12149)
Infectious disease (1510)
Inflammatory bowel disease (68)
IPO (6991)
Job creations (1843)
Job search strategy (381)
Layoffs (153)
Legal (3616)
Lung cancer (147)
Lymphoma (63)
Manufacturing (75)
Medical device (12755)
Medtech (12758)
Mergers & acquisitions (10023)
Metabolic disorders (289)
Neuroscience (933)
NextGen Class of 2024 (3931)
Non-profit (2817)
Northern California (882)
Obesity (166)
Opinion (63)
Parkinson's disease (59)
Patents (62)
People (34240)
Phase I (11358)
Phase II (17179)
Phase III (14106)
Pipeline (292)
Postmarket research (1667)
Preclinical (3541)
Radiopharmaceuticals (156)
Rare diseases (123)
Real estate (2843)
Regulatory (13796)
Research institute (1599)
Southern California (764)
Startups (2118)
United States (8549)
Vaccines (297)
Weight loss (115)
Date
Today (6)
Last 7 days (120)
Last 30 days (1230)
Last 365 days (19874)
2024 (19844)
2023 (22767)
2022 (30699)
2021 (33010)
2020 (32223)
2019 (28460)
2018 (21829)
2017 (18924)
2016 (18123)
2015 (21209)
2014 (16030)
2013 (13252)
2012 (14363)
2011 (14629)
2010 (13185)
Location
Africa (353)
Arizona (93)
Asia (24159)
Australia (3818)
California (1954)
Canada (885)
China (218)
Colorado (114)
Connecticut (114)
Delaware (66)
Europe (47116)
Florida (331)
Georgia (85)
Illinois (263)
Indiana (158)
Japan (59)
Kansas (67)
Maryland (462)
Massachusetts (1416)
Michigan (77)
Minnesota (196)
New Jersey (716)
New York (603)
North Carolina (423)
Northern California (882)
Ohio (92)
Pennsylvania (575)
South America (518)
Southern California (764)
Texas (331)
Utah (63)
Washington State (161)
376,089 Results for "paragon medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Paragon Therapeutics Appoints Susanna High as Chief Executive Officer
November 21, 2024
·
3 min read
Deals
AMETEK Completes Acquisition of Paragon Medical
AMETEK, Inc. (NYSE: AME) today announced that it has completed its acquisition of Paragon Medical, a leading provider of highly engineered medical components and instruments, from affiliates of American Securities LLC, in an all-cash transaction valued at approximately $1.9 billion.
December 8, 2023
·
1 min read
Business
Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance
Paragon 28, Inc., a leading medical device company exclusively focused on the foot and ankle orthopedic market, reported financial results for the quarter ended March 31, 2024, and reaffirmed its 2024 net revenue guidance.
May 8, 2024
·
12 min read
Deals
Elevance Health Announces Closing of Paragon Healthcare Acquisition
Elevance Health announced the closing of its acquisition of Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.
March 11, 2024
·
6 min read
BioMidwest
Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference
Paragon 28, Inc. announced that Albert DaCosta, Chairman and CEO, and Krissy Wright, Interim CFO, will participate in a fireside chat at the Bank of America Securities 2024 Healthcare Conference on Tuesday, May 14, 2024, at 5:00 p.m. Pacific Time / 6:00 p.m. Mountain Time.
May 2, 2024
·
1 min read
Deals
AMETEK Announces Agreement to Acquire Paragon Medical
AMETEK, Inc. announced that it has entered into a definitive agreement to acquire Paragon Medical, a leading provider of highly engineered medical components and instruments, from affiliates of American Securities LLC in an all-cash transaction valued at approximately $1.9 billion.
October 31, 2023
·
1 min read
Deals
Paragon Therapeutics Announces Oruka Therapeutics Has Entered into Merger Agreement with ARCA biopharma to Advance Novel Treatments for Chronic Skin Diseases
Paragon Therapeutics announced today that the third company founded based on assets generated by Paragon, Oruka Therapeutics (“Oruka”), has entered into a definitive agreement with ARCA biopharma to combine the companies in an all-stock transaction.
April 3, 2024
·
3 min read
Deals
Elevance Health to Acquire Paragon Healthcare
Elevance Health announced that it has entered into an agreement to acquire Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.
January 4, 2024
·
7 min read
Business
Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
Paragon 28, Inc. announced that Stephen Deitsch, Chief Financial Officer, has notified the Company of his intent to pursue an opportunity with OrganOx Limited, a commercial stage UK-based medical device company focused on therapeutic applications of isolated organ perfusion.
April 4, 2024
·
7 min read
Business
Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance
Paragon 28, Inc., a leading medical device company exclusively focused on the foot and ankle orthopedic market, reported financial results for the quarter and year ended December 31, 2023 and provided 2024 Net Revenue guidance.
February 29, 2024
·
15 min read
1 of 37,609
Next
